Literature DB >> 26632359

CRISPR/Cas9 and Germline Modification: New Difficulties in Obtaining Informed Consent.

Joanna Smolenski1.   

Abstract

Mesh：

Year:  2015        PMID： 26632359     DOI： 10.1080/15265161.2015.1103816

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN： 1526-5161            Impact factor:   11.229


× No keyword cloud information.
  5 in total

1.  Toward Anticipatory Governance of Human Genome Editing: A Critical Review of Scholarly Governance Discourse.

Authors:  John P Nelson; Cynthia L Selin; Christopher T Scott
Journal:  J Responsible Innov       Date:  2021-07-29

Review 2.  Responsible Translational Pathways for Germline Gene Editing?

Authors:  Bryan Cwik
Journal:  Curr Stem Cell Rep       Date:  2020-08-21

3.  Trust in Science: CRISPR-Cas9 and the Ban on Human Germline Editing.

Authors:  Stephan Guttinger
Journal:  Sci Eng Ethics       Date:  2017-06-26       Impact factor: 3.525

Review 4.  Ethical issues related to research on genome editing in human embryos.

Authors:  Emilia Niemiec; Heidi Carmen Howard
Journal:  Comput Struct Biotechnol J       Date:  2020-03-21       Impact factor: 7.271

5.  Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.

Authors:  Sebastian Schleidgen; Hans-Georg Dederer; Susan Sgodda; Stefan Cravcisin; Luca Lüneburg; Tobias Cantz; Thomas Heinemann
Journal:  BMC Med Ethics       Date:  2020-09-11       Impact factor: 2.652
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.